Bryan Traughber, MD
Radiation Oncology · Rochester, MNNPI 1609049873
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Angiodynamics, Inc. at 47.1% of the total. Reporting peaked in 2020 at $1,895 and has fallen 80.8% since, to $363 in 2025.
Across 28 payments — averaging $136.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$2K
- Siemens Medical Solutions USA, Inc.$1K
- GE HealthCare$472
- Elekta, Inc.$164
- Clovis Oncology, Inc.$95
Across 16 payments — averaging $15,303 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viewray Technologies Inc$200K
- Pfizer$37K
- Siemens Medical Solutions USA, Inc.$8K
What the payments were for
- Consulting fees$1,80047%
- Travel & lodging$41211%
- Food & beverage$1,60642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 1 | $1,800 |
| Siemens Medical Solutions USA, Inc. | 19 | $1,288 |
| GE HealthCare | 5 | $472 |
| Elekta, Inc. | 2 | $164 |
| Clovis Oncology, Inc. | 1 | $95 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Biograph mMR$282
- MAGNETOM Free.Max$166
- ELEKTA UNITY$134
How this compares
$3,818 in reported general payments places this provider in the 85th percentile of 128 radiation oncology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 12 | $189 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Rochester
- Aadel ChaudhuriRochester$37K
- Brian DavisRochester$28K
- Jann SarkariaRochester$26K
- Daniel ChamberlainRochester$21K
- Kenneth MerrellRochester$14K
- Meng WelliverRochester$13K
- Tyler WilhiteRochester$5K
- Aurelie GarantRochester$4K
- Sean ParkRochester$4K
- Eric LehrerRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.